Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 180,18
Quantità: 1 disponibili
Aggiungi al carrellopaperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Da: Majestic Books, Hounslow, Regno Unito
EUR 80,09
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 80,06
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Da: moluna, Greven, Germania
EUR 41,05
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Walimbe ChaitanyaMr. Chaitanya Walimbe is a M. Pharma (Pharmaceutics) researcher from Appasaheb Birnale college of pharmacy under Shivaji University, Kolhapur, India. He has completed his major research work in Formulation and Evalua.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3659219762 ISBN 13: 9783659219764
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 49,59
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Lipid-based drug delivery systems are expected as promising oral carriers because of their potential to increase the solubility and improve oral bioavailability of poorly water-soluble and/or lipophilic drugs and are attracting major attention as alternative colloidal drug carriers. Traditional lipid-based formulations include a broad range of lipid solution, emulsions, liposomes, lipid microparticles and nanoparticles. Among the formulations above, the nanostructure lipid carriers (NLCs) are regarded as the second-generation of lipid nanoparticlesThe purpose of this study is to develop an optimized nanostructured lipid carriers (NLC) formulation for Ritonavir, and to estimate the potential of NLC as oral delivery system for poorly water-soluble drugs.